Loading clinical trials...
Loading clinical trials...
The objective of this study is to evaluate the long-term safety and effectiveness of Humira in patients with Hidradenitis Suppurativa (HS) in real-world clinical practice in Japan.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
AbbVie
NCT06993233 · Hidradenitis Suppurativa (HS)
NCT07316192 · Hidradenitis Suppurativa (HS)
NCT07155239 · Hidradenitis Suppurativa (HS)
NCT07021495 · Chronic Spontaneous Urticaria (CSU), Hidradenitis Suppurativa (HS), and more
NCT07123038 · Rheumatoid Arthritis (RA), Hidradenitis Suppurativa (HS)
Anjou Kousei Hospital /ID# 216741
Anjo-shi, Aichi-ken
Ichinomiya Municipal Hospital /ID# 214086
Ichinomiya-shi, Aichi-ken
Aichi Medical University Hospital /ID# 215312
Nagakute-shi, Aichi-ken
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions